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Helena Carreira1,2*, Marta Pereira1,2, Ana Azevedo1,2 and Nuno Lunet1,2Abstract
Background: Understanding the dynamics of smoking at the population level is essential for the planning and
evaluation of prevention and control measures. We aimed to describe trends in the prevalence of smoking in
Portuguese adults by sex, age-group and birth cohort.
Methods: PubMed was searched from inception up to 2011. Linear regression was used to assess differences in
prevalence estimates according to the type of population sampled, and to estimate time trends of smoking
prevalence considering only the results of studies on nationally representative samples of the general population.
Results: Thirty eligible studies were identified. There were statistically significant differences in the prevalence
estimates according to the types of population sampled in the original studies. Between 1987 and 2008, the
prevalence of smoking increased significantly among women aged ≤ 70 years; the steepest increase was observed
in those aged 31–50 and 51–70 years (from 4.6% and 0.1% in 1988, respectively, to 16.4% and 4.5% in 2008,
respectively). The prevalence of smoking increased in all birth cohorts, except for those born before 1926. In the
same period, among men, smoking decreased in all age-groups, with steepest declines in those aged ≤ 30 years
(from 41.8% in 1988 to 28.8% in 2008) and those aged ≥ 71 years (from 15.1% in 1988 to 4.6% in 2008). The
prevalence of smoking declined among men of all birth cohorts.
Conclusions: This study provides robust evidence to place Portuguese women at stage II and men at the later
stages of the tobacco epidemic.
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Smoking is the main preventable cause of premature
death [1]. In 2004, it caused nearly 5 million deaths
worldwide, accounting for approximately 25% and 7% of
the mortality among adult European men and women,
respectively [2]. In Portugal, in 2005, it was estimated
that 18% of the deaths in men and 5% in women were
attributable to smoking, accounting for more than 70
thousand disability-adjusted life years [3].
The most comprehensive data on smoking in Portugal
comes from the four National Health Surveys [4-7] and
from several Eurobarometer surveys [8-14]. However,
most of the latter did not provide sex- and age-specific* Correspondence: hcarreira@med.up.pt
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reproduction in any medium, provided the orestimates, which are essential to plan, monitor and
evaluate the impact of prevention and control measures.
Other studies assessed smoking behaviours in different
calendar years, mainly from smaller regional samples
recruited across the country, but the usefulness of these
estimates has not been systematically addressed before.
A general model for the tobacco epidemic is widely
accepted [15], though not all countries followed the
same pattern as the ones used to formulate this model a
few decades ago [16]. Country-specific data on the pat-
terns of smoking at a population level are, therefore,
necessary to understand its dynamics in each setting.
We conducted a comprehensive systematic review of
studies that quantified the prevalence of smoking in Por-
tuguese adults. Our specific aims were to compare the
estimates obtained from studies that evaluated popula-
tions with different characteristics and to estimate thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Methods
Search strategy
We searched PubMed from inception up to January
2011, to identify original studies and review articles
addressing the distribution of smoking in samples of
the Portuguese adult population. The detailed search
expression is presented in the systematic review flow-
chart (Additional file 1: Figure S1). This is a comprehen-
sive search expression that includes terms directly
related with smoking behaviours (“smoking”, “smoke”,
“tobacco”, “cigarette”), as well as with other cardiovascu-
lar risk factors (hypertension, obesity, dyslipidaemia, dia-
betes, physical inactivity). The latter were also included
because smoking is frequently associated with other
behaviours with potential impact in human health
[17,18], and therefore reports with primary objectives
not directly related with the assessment of smoking
behaviours may also provide data of interest for this re-
view, as secondary results. The reference lists of the re-
view articles addressing the distribution of
cardiovascular risk factors were screened to identify po-
tentially eligible original reports. Additionally, we
searched for reports that are by nature not suitable for
indexation in journal databases (e.g. Eurobarometer
study).
Eligibility criteria and screening of reference lists
Two reviewers independently evaluated the studies in
three consecutive steps, following predefined criteria, to
determine the eligibility of each report. The first two
steps relied on the same criteria. In step 1, the exclusion
of irrelevant studies was decided by considering only the
title and abstract; when the abstract of a particular article
was not available, the article was selected for evaluation
in step 2, except when the title unequivocally presented
information for exclusion (e.g. case report, studies of risk
factors in a specified population). The full text of studies
selected for step 2 were then evaluated to decide on their
eligibility. The studies selected for step 3 were re-
evaluated to determine their adequacy for extraction of
relevant data.
The criteria for exclusion of studies were the following:
reports not written in Portuguese, English, Spanish, French
or Italian; studies not involving humans (e.g. in vitro or
animal research); editorials, reviews or comments; reports
not providing data specifically for Portuguese subjects;
studies not evaluating adult populations; studies in which
sample selection was dependent of at least one cardiovas-
cular risk factor (hypertension, obesity, dyslipidaemia, dia-
betes or physical inactivity) and therefore participants
could not represent the general population regarding theprevalence of smoking (e.g. subjects with diabetes, athletes,
sedentary elderly); insufficient characterization of the
methods (e.g. not specifying the region where the sample
was assembled); not presenting sex-specific data on smok-
ing. We did not exclude from the systematic review the
studies presenting data not stratified by age, although these
were not eligible for all data synthesis.
When more than one report referred to the same
study, we considered the one providing data for the
largest sample or, when the sample was the same, we
used the source presenting the results with more detail,
although any of these reports could be used to obtain
information on the study characteristics.
The disagreements between the independent assess-
ments of the reviewers were resolved by consensus or
after discussion with a third researcher.
Data extraction
Two investigators independently evaluated the selected
studies to extract the following data for sample
characterization: sex; age; sample size; type of population
(general population, university students, occupational
groups, users of primary health care centers or volun-
teers); sampling strategy (probability or non probability
sampling); geographical coverage (national or regional).
We considered the study population to be general
population when subjects were randomly selected from
the electoral rolls or recruited from the registries of the
primary health care centers. The latter were considered
general population because in Portugal the access to the
National Health Service is universal and in theory every-
one is registered, including those who do not use it as
the main source of health care. The studies that evalu-
ated samples of the general population were further
divided according to the geographical coverage of the
study, into regional or national representative samples.
University students, occupational groups, users of pri-
mary health care centers (when subjects were recruited
among the attendants to health care centers or data
were abstracted from clinical records) and volunteers
(when subjects took some initiative to participate in the
survey) were considered different types of population.
We extracted age-specific prevalence estimates of
current smoking, whenever available. Due to the large
heterogeneity in the criteria to define classes of smoking,
we considered that the data referred to current smoking
when described in the original reports as: “currently
smoking”; “currently smoking or had ceased for less than
one year”; “smoking cigarettes but not as many as one
per day, or smoking more than one cigarette per day, or
smoking pipe or cigars”; “regular smoking”; “smoking
daily”; “smoking daily for at least six months”.
The mean age of each age-group was extracted, when-
ever available. For the studies that did not present the
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assumed the mid-point of the age interval; for the open
age intervals at the extremes we estimated the mid-point
by adding and subtracting the width of the closest class to
the upper and to the lower limits, respectively (e.g. for
surveys reporting data in participants aged < 30, 30–39,
40–49, and ≥ 50 years, we considered the overall range as
20–59 years). When an age-group also included subjects
aged below 18 years old (e.g. 17–20 years), we computed
the mid-point and excluded the data if the mid-point year
was lower than 17.5 years old.
We obtained age- and sex-specific estimates directly
from the authors of three studies [7,19,20], including
one of the largest regional surveys and two national
surveys.
Differences in the data extracted by the two investigators
were discussed until consensus, and involving a third inves-
tigator whenever necessary.
Data analysis
We compared the estimates of current smoking across
the different types of population, considering national
representative samples of the general population as the
reference class. To quantify these differences, we fitted
sex-specific multiple linear regression models, adjusting
for the mean age of the participants (continuous vari-
able), the year of survey (continuous variable), the smok-
ing measure involved (daily smoking/current smoking,
categorical variable) and geographical coverage of the
study (national/regional, categorical variable). Since
more than one estimate of the smoking prevalence could
be extracted from each report, corresponding to differ-
ent age strata, the confidence intervals derived from the
multiple linear regression models were calculated using
robust estimates of the standard errors [21], to account
for the dependence between the observations from the
same study.
To estimate the time trends of the prevalence of smok-
ing, we considered only the results of the studies that
evaluated samples with national coverage that were rep-
resentative of the general population [14,20,22-24]. We
conducted sex-specific stratified analyses for four age-
groups and according to birth cohorts. We selected the
age-groups ≤ 30, 31–50, 51–70 and > 70 to represent
young, young middle aged, middle aged and older subjects.
As some of the studies included in the review evalu-
ated samples of subjects in a wide range of ages, and
therefore the estimated mid-point of the age-group may
not correspond to an accurate estimation of the age of a
large proportion of the subjects evaluated, we excluded
the results of these studies from the time trends analyses
[14,24].
To compute the year of birth of the participants, we
subtracted the mid-point age of each age-group fromthe calendar year of the survey. This variable was further
categorized using the quartiles of the distribution as cut-
offs: ≤ 1926; 1927–1946; 1947–1959; ≥ 1960.
The results are presented in figures, describing the
sex-specific variation of the smoking prevalence over
time for each age group and birth cohort. We included
in the figures only one estimate per age-group from each
study. When studies reported estimates by strata of age
that were narrower than the age-agroups we defined for
analysis, it corresponded to the average of the prevalence
in the narrower age strata, weighted by the correspond-
ing number of participants. Each figure also includes a
line representing the linear or quadratic (whenever sig-
nificantly different from the linear) prediction of the
prevalence of current smoking as a function of the year
of survey.
We also provide estimates of the prevalence of smoking
obtained from the linear regression models in selected
calendar years, for each age-group and birth cohort.
Results
Systematic review
Thirty studies were eligible for the systematic review.
Detailed information on their main characteristics, as
well as the respective prevalence estimates, are provided
in the Additional file 1: Table S1. The reports were
published between 1990 and 2012, and referred to data
collected between 1987 and 2012.
Estimates of current smoking in women and in men were
available from 26 and 28 reports, respectively, 8 of which
evaluated mainland/national samples. The studies were
conducted in 5 different types of population, including gen-
eral population (n = 14), occupational groups (n = 3), uni-
versity students (n = 6), users of primary health care
centers (n = 6) and volunteers (n = 1) (Additional file 1:
Table S1).
Estimates of the prevalence of current smoking according
to the type of population
Having as reference the results from the 6 studies that
evaluated national samples of the general population
and provided age-stratified estimates, the prevalence of
current smoking among women, adjusted for the age of
the participants, year of survey and measure of smoking
involved, was significantly higher in primary health care
users [4.6%; 95% confidence interval (95% CI): 2.1 to
7.0]. Among men, the prevalence of current smoking
was significantly higher in regional samples of the gen-
eral population (7.0%; 95% CI: 0.1 to 13.4) and primary
health care centres users (5.3%; 95% CI: 2.7 to 7.9); it
was significantly lower in samples of specific occupa-
tional groups (−12.5%; 95% CI: -16.2 to −8.8), volunteers
(−7.5%; 95% CI: -8.9 to −6.1) and university students
(−13.4%; 95% CI: -24.5 to −2.4) independently of the age
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define smoking (Figure 1).Trends in smoking prevalence in the general population
Between 1988 and 2008, the prevalence of current
smoking increased significantly among women of all
ages, except in those older than 70 years (Figure 2).
The steepest increase was observed in those aged 31–
50 years and 51–70 years (from 4.6% and 0.1% in
1988, respectively, to 16.4% and 4.5% in 2008, respect-
ively); a less pronounced upward trend was reported in
younger women (Figure 2 and Table 1). The preva-
lence of smoking increased in all cohorts, except in
women born before 1926, though the absolute vari-
ation was much smaller than the observed in the ana-
lysis by age-group (Figure 3 and Table 1).
In the same 20 year-period, the prevalence of smoking
among men decreased in all age-groups, with steepest
declines observed among those aged ≤ 30 years (from
41.8% in 1988 to 28.8% in 2008) and those aged ≥ 71
years (from 15.1% in 1988 to 4.6% in 2008) (Figure 2
and Table 1). The prevalence of smoking has declined
linearly among men born between 1927 and 1946, andFigure 1 Differences in the estimates of the prevalence of current sm
comparison with samples of the general population with national rep
estimated using sex-specific models including the prevalence of smoking a
participants (continuous variable), the year of survey (continuous variable),
variable) and the smoking measurement (current smoking/daily smoking, c
as independent variables.in those born after 1960. For the cohorts of men born
before 1926, the prevalence decreased, mainly before
1995, and stabilized thereafter, while among those born
between 1947 and 1959 a steep decline was observed
only in the second half of the period of analysis
(Figure 3).Discussion
This study shows that in the last decades the smoking
prevalence increased markedly among Portuguese
women, while it decreased among men. The results from
the studies involving samples of the general population
without national representativeness overestimate the
national prevalence of smoking, showing that these
studies are of limited interest when the purpose is to
estimate time trends in the general population.
Smoking is strongly associated with morbidity, and the
lower prevalence observed in the samples of specific
occupational groups may result from selection bias, as
subjects need to be healthy enough to be active workers
and those who develop diseases are more likely to leave
their employment [25]. Among workers, smoking has
also been associated with greater absenteeism andoking according to the type of population sampled, in
resentativeness, in women and men. The prevalences were
s dependent variable and the type of population, the mean age of
the geographical coverage of the study (national/regional, categorical
ategorical variable) of the study
Figure 2 Trends in the prevalence of smoking in different age group, by sex. Only were considered the results of the studies involving
national representative samples of the general population. When a given study provided more than one estimate for each of the age groups
computed, we computed the weighted mean of the prevalence of smoking. Studies involving samples with a wide age-range and not
presenting age-stratified data were excluded.
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of smokers being selected for the epidemiological
investigations.
In the only study whose participants we considered
volunteers, the healthy volunteer effect is likely to have
occurred, as those who have a proactive attitude to
participate in a survey tend to be more sensitive to
health messages than the average person from the general
population [28,29].
Primary health care users had significantly higher
levels of smoking, both in women and in men. Smoking
is strongly associated with a higher incidence of several
chronic diseases [30,31] and the prevalence estimates for
this group may reflect the increased use of health care
services by smokers.
The gender differences in the prevalence of smoking
among university students are likely to be explained by
Portuguese women being at earlier stages of the smoking
epidemic than men.
According to the most recent update of the smoking
epidemic model [16], among women the stage II is
characterized by a rapid increase of the prevalence of
smoking, along with few deaths attributable to smoking;
stage III starts when the peak prevalence is achieved. OurFigure 3 Trends in the prevalence of smoking in different birth cohorresults on the trends in the prevalence of smoking place
Portuguese women in the second stage of the epidemic
[15,16]. However, between 1955 and 2005, the lung can-
cer mortality rates increased 1.6% (95% CI: 1.4% – 1.8%)
per year among Portuguese women (35–74 years) [32],
which is compatible with both the end of stage II and
stage III of the smoking epidemic.
The data referring to men suggest an ongoing transi-
tion from the third to the fourth phase of the smoking
epidemic. In phase III, the prevalence of smoking begins
to decline, while the smoking-attributable mortality rises
rapidly [15,16]. In phase IV, the prevalence continues to
decline while the mortality attributable to smoking peaks
in the beginning of this stage and declines thereafter
[15,16]. Among Portuguese men aged 35 to 74 years, be-
tween 1986 and 1996, the annual percent change (APC)
in the lung cancer mortality rate was 1.52% (95% CI:
0.59% to 2.46%), and between 1996 and 2005 the rates
stabilized (APC: -0.15%, 95% CI: -0.99% to 0.69%) [32].
Previous studies involving cross-sectional analyses have
placed Portugal at earlier stages of the epidemic than most
European countries [23,33]; Spain, the neighbour country,
is at the beginning of stage IV [34]. We put forward a sex-
specific classification for the Portuguese population, ints, by sex.
Table 1 Estimated prevalence of smoking by age group and birth cohort
Estimated prevalence of smoking (%) and 95% confidence intervals *
Women Men
1988† 1998† 2008† 1988† 1998† 2008†
Age group
≤ 30 years 12.4 (8. 3 to 16.5) 14.4 (12.0 to 16.9) 15.9 (12.4 to 19.3) 41.8 (30.6 to 52.9) 35.3 (28.7 to 41.9) 28.8 (18.0 to 39.7)
31 – 50 years 4.6 (3.0 to 6.3) 10.5 (9.4 to 11.6) 16.4 (15.7 to 17.2) 39.3 (32.2 to 46.4) 36.9 (32.9 to 40.8) 34.4 (27.4 to 41.5)
51 – 70 years 0.1 (0.0 to 2.4) 2.3 (1.0 to 3.5) 4.5 (2.2 to 6.7) 24.8 (18.7 to 30.9) 20.9 (15.9 to 25.9) 16.9 (12.2 to 21.6)
≥ 71 years 0.1 (0.0 to 0.7) 0.5 (0.2 to 1.0) 0.9 (0.0 to 2.1) 15.1 (10.9 to 19.3) 9.9 (7.2 to 12.6) 4.6 (2.4 to 6.8)
Birth cohort
≤ 1926 0.3 (0.0 to 1.0) 0.5 (0.1 to 1.0) 0.0 (0.0 to 1.2) 15.5 (8.5 to 22.5) 7.3 (1.5 to 13.1) 6.8 (0.0 to 19.3)
1927 – 1946 0.6 (0.0 to 2.8) 1.5 (0.3 to 2.6) 2.3 (0.3 to 4.3) 26.1 (14.3 to 37.8) 18.3 (12.3 to 24.3) 10.5 (0.0 to 21.2)
1947 – 1959 6.3 (0.0 to 17.3) 7.1 (0.2 to 14.0) 7.9 (0.0 to 19.9) 37.3 (3.1 to 71.4) 37.0 (8.3 to 65.8) 17.5 (0.0 to 57.0)
≥ 1960 12.0 (9.3 to 14.7) 13.9 (12.5 to 15.3) 15.9 (13.8 to 18.1) 42.5 (34.6 to 50.4) 37.1 (33.0 to 41.1) 31.6 (25.4 to 37.9)
* Prevalence estimated from sex-specific linear regression model, for each age group and birth cohort;
† The years 1988 and 2008 were selected because correspond approximately to the first year and last years with available data, respectively, and 1998 because is
the mid-point of this period.
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demic model [16]. The earlier stage proposed for women
might be a consequence of Portugal’s lower economic and
social development, which may have determined a slower
spread of the epidemic among the less educated women
who are particularly affected by prices increases [35,36].
Portugal may take advantage of this position among
women, by implementing effective public health measures
to curb the trends observed and to avoid the harmful
effects of smoking in the next decades.
The present review is based on an extensive literature
search and provides a comprehensive summary of the
best available evidence on the prevalence of smoking in
Portugal. However, there are some limitations that need
to be addressed.
The studies included in the systematic review are
heterogeneous in what concerns the criteria to define
smoking, involving measures of current and daily
smoking, possibly contributing to an underestimation
of the smoking prevalence and trends in Portugal.
However, there were no statistically significant differ-
ences according to the criteria involved and a sensitivity
analysis that excluded the studies only providing data on
daily smoking yielded virtually the same results.
Another limitation of this study results from the inclu-
sion of samples of subjects aged above 18 years, while
the smoking behaviours of the population aged above 15
years are important for a more comprehensive under-
standing of the dynamics of smoking and the tobacco
epidemic.
Portugal signed the World Health Organization
Framework Convention on Tobacco Control and already
adopted measures to control tobacco consumption.
These include health warnings in the cigarette packages,
tax increases and, more recently, a law regulating theuse of tobacco in restaurants and other public places,
aiming to protect subjects from passive smoking expos-
ure [37]. The strict enforcement of the latter measure
occurred in 2008 and may have had a greater impact on
the smoking behaviours of the population. However, we
only obtained age-stratified data on the smoking preva-
lence until 2008 and therefore the impact of this measure
could not be ascertained in the present study.
After 1998, the smoking prevalence has been declin-
ing among all birth cohorts of men. This is in accord-
ance with the decreasing sales of tobacco products in
Portugal, which were estimated to be nearly 18 billion
cigarettes in 2002, and less than 12 billion in 2011 [38].
Notwithstanding, the trends reported in this study, es-
pecially among women, demand for the reinforcement
of the existing policies and for more effective policies
targeting the whole population. In Portugal the percent-
age of per capita gross domestic product needed to pur-
chase 100 packs of cigarettes was 1.66 in 1990 and 1.76
in 2006, representing a small change in the cigarettes af-
fordability in the country over the last decades [39].
Price increases have been associated with reduced con-
sumption and quitting smoking [40], and tax increases
may be particularly important in the current local sce-
nario of economic and financial crisis. Furthermore,
they have the potential to affect particularly lower
socio-economic groups, among whom the prevalence of
smoking is higher in men [23] and expected to increase
among women [19]. Other measures, such as the pro-
motion of the smoking cessation clinics already existing
in the country and the creation of new ones, as well as
the free provision of nicotine-replacement therapies and
other similar aids, may contribute to downward trends
[41]. The monitoring of the epidemic should also con-
sider the study of other tobacco products expected to be
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purchasing power [40].
Conclusions
Our results place Portuguese women in the stage II of
the smoking epidemic, while men are at the later stages,
between stages III and IV.
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